Advertisement
Screener

CALLISTO PHARMACEUTICALS INC Net Cash Provided by (Used in) Continuing Operations

CALLISTO PHARMACEUTICALS INC Net Cash Provided by (Used in) Continuing Operations

CALLISTO PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Continuing Operations of $120 for the 196-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2012-11-19

  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-09-30 was $0.00.
  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-06-30 was -$6.12M.
  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-03-31 was -$7.12M.
  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2011-12-31 was $13.18M, a 1085.03% increase year-over-year.
  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2011 was $11.54M.
  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2010 was -$5.50M, a 179.62% decline from fiscal 2009.
  • CALLISTO PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2009 was $6.91M.
Period endNet Cash Provided by (Used in) Continuing Operations 3 monthNet Cash Provided by (Used in) Continuing Operations 6 monthNet Cash Provided by (Used in) Continuing Operations 9 monthNet Cash Provided by (Used in) Continuing Operations 12 monthNet Cash Provided by (Used in) Continuing Operations 184 monthNet Cash Provided by (Used in) Continuing Operations 187 monthNet Cash Provided by (Used in) Continuing Operations 190 monthNet Cash Provided by (Used in) Continuing Operations 193 monthNet Cash Provided by (Used in) Continuing Operations 196 month
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
-$6.12M
derived: sum of 2 quarters · filed 2012-11-19
-$13.24M
10-Q · filed 2012-11-19
-$67.35K
derived: sum of 4 quarters · filed 2012-11-19
$120.00
10-Q · filed 2012-11-19
2012-06-30-$6.12M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28
-$13.24M
10-Q/A · filed 2012-08-28
-$67.35K
derived: sum of 3 quarters · filed 2012-08-28
-$597.98K
derived: sum of 4 quarters · filed 2012-11-19
$120.00
10-Q/A · filed 2012-08-28
2012-03-31-$7.12M
10-Q · filed 2012-05-15
$6.06M
derived: sum of 2 quarters · filed 2012-05-15
$5.53M
derived: sum of 3 quarters · filed 2012-11-19
$5.18M
derived: sum of 4 quarters · filed 2012-11-19
$6.12M
10-Q · filed 2012-05-15
2011-12-31$13.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$12.65M
derived: sum of 2 quarters · filed 2012-11-19
$12.31M
derived: sum of 3 quarters · filed 2012-11-19
$11.54M
10-K · filed 2012-03-30
$13.24M
10-K · filed 2012-03-30
2011-09-30-$530.63K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
-$871.30K
derived: sum of 2 quarters · filed 2012-11-19
-$1.64M
10-Q · filed 2012-11-19
-$529.51K
derived: sum of 4 quarters · filed 2012-11-19
$67.47K
10-Q · filed 2011-11-14
2011-06-30-$340.67K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-28
-$1.11M
10-Q/A · filed 2012-08-28
$1.12K
derived: sum of 3 quarters · filed 2012-08-28
2011-03-31-$770.21K
10-Q · filed 2012-05-15
$341.79K
derived: sum of 2 quarters · filed 2012-05-15
2010-12-31$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
-$5.50M
10-K · filed 2012-03-30
2010-09-30-$6.61M
10-Q · filed 2011-11-14
2009-12-31$6.91M
10-K · filed 2012-03-30